OmniPathology Receives FDA Emergency Use Authorization for New Omni-COVID-19 Molecular Test
June 22, 2020 08:45 ET
|
OmniPathology
PASADENA, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- OmniPathology today announced that it has received an FDA Emergency Use Authorization EUA letter for its Omni-COVID-19 Assay polymerase chain...
Aegea Biotechnologies, Inc. Announces the Issuance of 7 Additional Key U.S. Patents Relating to its Core, Next Generation Nucleic Acid Clinical Diagnostic Technologies and COVID-19 Test Development
May 18, 2020 08:13 ET
|
Tauriga Sciences
NEW YORK, NY and SAN DIEGO, CA, May 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Aegea Biotechnologies, Inc. ( “Aegea”) ( www.aegeabiotech.com), a biotechnology company focusing on the...
OmniPathology Releases New COVID-19 Testing for Greater Los Angeles
March 24, 2020 14:42 ET
|
OmniPathology
PASADENA, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- OmniPathology today announced the launch of its COVID-19 Lab Developed Test LDT. In response to the US Food and Drug Administration (FDA) policy...
No Borders, Inc. (Ticker:NBDR) Subsidiary MediDent Supplies Announces New Stay At Home 15 Minute COVID-19 Blood Tests
March 23, 2020 11:12 ET
|
No Borders, Inc.
Phoenix, AZ, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- No Borders, Inc. (OTC:NBDR), today announced that the Company has executed an agreement with its existing suppliers in Hong Kong...
No Borders, Inc. (Ticker:NBDR) Subsidiary MediDent Supplies Launches Stay at Home Covid-19 Home Specimen Collection Kit Nationwide
March 16, 2020 13:33 ET
|
No Borders, Inc.
Phoenix, AZ, March 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- No Borders, Inc. (OTC:NBDR) today announced the launch of its “MediDent Supplies Covid-19 Home Specimen Collection Kit” to support...